Literature DB >> 16871135

Sexual dysfunction and psychotropic medications.

Glen L Stimmel1, Mary A Gutierrez.   

Abstract

Psychotropic drugs are often associated with sexual dysfunction. The frequency of antidepressant-associated sexual dysfunction is greatly underestimated in clinical trials that rely on patient self-report of these adverse events. Direct inquiry reveals that delayed orgasm/ejaculation occurs in >50% and anorgasmia in at least one third of patients given selective serotonin reuptake inhibitors. Antidepressant-induced sexual dysfunction can be successfully managed. A different antidepressant without significant sexual effects, such as bupropion or mirtazapine, can often be substituted. Other strategies involve drug holidays or adjunctive therapy with drugs such as sildenafil. Dopamine antagonist antipsychotic drugs are most commonly associated with decreased libido. The newer atypical antipsychotics, with less effect on dopamine, are less commonly associated with sexual dysfunction. Sexual dysfunction is commonly reported with seizure disorders, and many anticonvulsant drugs affect levels of sex hormones. Because sexual dysfunction can be related to many factors, care must be taken to establish the patient's baseline sexual functioning before the initiation of psychotropic drug therapy and to rule out other etiologies before drugs are implicated as causative.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871135     DOI: 10.1017/s1092852900026730

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  9 in total

1.  Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study.

Authors:  Guneet K Jasuja; Shalender Bhasin; Joel I Reisman; Joseph T Hanlon; Donald R Miller; Anthony P Morreale; Leonard M Pogach; Francesca E Cunningham; Angela Park; Dan R Berlowitz; Adam J Rose
Journal:  J Gen Intern Med       Date:  2016-12-19       Impact factor: 5.128

Review 2.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

3.  An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients.

Authors:  Mehmet A Ersoy; Aysin M Noyan; Hayriye Elbi
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

4.  An update on female sexual function and dysfunction in old age and its relevance to old age psychiatry.

Authors:  Alison Wood; Ross Runciman; Kevan R Wylie; Ross McManus
Journal:  Aging Dis       Date:  2012-08-25       Impact factor: 6.745

5.  Sexual Dysfunction among Females Receiving Psychotropic Medication: A Hospital-based Cross-sectional Study.

Authors:  Veda N Shetageri; Govind S Bhogale; N M Patil; R B Nayak; S S Chate
Journal:  Indian J Psychol Med       Date:  2016 Sep-Oct

6.  Prevalence and Predictors of Female Sexual Dysfunction in Migraine.

Authors:  R Pradeep; Harsha Sundarmurthy; Vivek Karan; Praveen Kulkarni
Journal:  Ann Indian Acad Neurol       Date:  2019 Jul-Sep       Impact factor: 1.383

Review 7.  Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach.

Authors:  Angel L Montejo; Rubén de Alarcón; Nieves Prieto; José Mª Acosta; Bárbara Buch; Laura Montejo
Journal:  J Clin Med       Date:  2021-01-15       Impact factor: 4.241

8.  Changes of androgens levels in menopausal women.

Authors:  Maria Brzozowska; Andrzej Lewiński
Journal:  Prz Menopauzalny       Date:  2021-01-07

Review 9.  Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.

Authors:  Kristin Heuschkel; Kim P C Kuypers
Journal:  Front Psychiatry       Date:  2020-03-31       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.